APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biosuperior

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biosuperior Industry Growth and Trends Forecast to 2032

20 December 2025103 pages

Choose your research edition.

Industry ResearchBiosuperior Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosuperior Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Biosuperior Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosuperior Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosuperior Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Biosuperior market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biosuperior is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biosuperior is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biosuperior is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biosuperior include Teva, Sanofi, Novo Nordisk, Merck and Co., Eli Lily and Company, Biogen, SERVIER, Porton Biopharma and F.Hoffmann-La Roche AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biosuperior market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biosuperior market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biosuperior market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biosuperior.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biosuperior market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biosuperior Market by Company

Teva

Sanofi

Novo Nordisk

Merck and Co.

Eli Lily and Company

Biogen

SERVIER

Porton Biopharma

F.Hoffmann-La Roche AG

CSL Behring GmbH

Biosuperior Segment by Type

Insulin Biobetters

Monoclonal Antibodies Biobetters

Erythropoietin Biobetters

G-CSF Biobetters

Others

Biosuperior Segment by Application

Genetic Disease

Diabetes

Neurological Disorders

Cancer

Others

Biosuperior Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosuperior market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosuperior and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosuperior.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biosuperior manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biosuperior in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Biobetters Table 2. Major Company of Monoclonal Antibodies Biobetters Table 3. Major Company of Erythropoietin Biobetters Table 4. Major Company of G-CSF Biobetters Table 5. Major Company of Others Table 6. Global Biosuperior Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biosuperior Sales by Type (2021-2026) & (k units) Table 8. Global Biosuperior Sales Market Share in Volume by Type (2021-2026) Table 9. Global Biosuperior Sales by Type (2021-2026) & (US$ Million) Table 10. Global Biosuperior Sales Market Share in Value by Type (2021-2026) Table 11. Global Biosuperior Price by Type (2021-2026) & (US$/unit) Table 12. Global Biosuperior Sales by Type (2027-2032) & (k units) Table 13. Global Biosuperior Sales Market Share in Volume by Type (2027-2032) Table 14. Global Biosuperior Sales by Type (2027-2032) & (US$ Million) Table 15. Global Biosuperior Sales Market Share in Value by Type (2027-2032) Table 16. Global Biosuperior Price by Type (2027-2032) & (US$/unit) Table 17. North America Biosuperior Sales by Type (2021-2026) & (k units) Table 18. North America Biosuperior Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Biosuperior Sales by Type (2021-2026) & (k units) Table 20. Europe Biosuperior Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Biosuperior Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Biosuperior Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Biosuperior Sales by Type (2021-2026) & (k units) Table 24. Latin America Biosuperior Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Biosuperior Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Biosuperior Sales by Type (2021-2026) & (US$ Million) Table 27. Biosuperior Industry Trends Table 28. Biosuperior Industry Drivers Table 29. Biosuperior Industry Opportunities and Challenges Table 30. Biosuperior Industry Restraints Table 31. Global Biosuperior Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Biosuperior Revenue Market Share by Company (2021-2026) Table 33. Global Biosuperior Sales by Company (2021-2026) & (k units) Table 34. Global Biosuperior Sales Share by Company (2021-2026) Table 35. Global Biosuperior Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Biosuperior Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Biosuperior Major Company Production Sites and Headquarters Table 38. Global Biosuperior Company, Product Type & Application Table 39. Global Biosuperior Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Biosuperior by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Biosuperior Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Biosuperior Sales by Region (2021-2026) & (k units) Table 44. Global Biosuperior Sales Market Share in Volume by Region (2021-2026) Table 45. Global Biosuperior Sales by Region (2021-2026) & (US$ Million) Table 46. Global Biosuperior Sales Market Share in Value by Region (2021-2026) Table 47. Global Biosuperior Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Biosuperior Sales by Region (2027-2032) & (k units) Table 49. Global Biosuperior Sales Market Share in Volume by Region (2027-2032) Table 50. Global Biosuperior Sales by Region (2027-2032) & (US$ Million) Table 51. Global Biosuperior Sales Market Share in Value by Region (2027-2032) Table 52. Global Biosuperior Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Biosuperior Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Biosuperior Sales by Application (2021-2026) & (k units) Table 55. Global Biosuperior Sales Market Share in Volume by Application (2021-2026) Table 56. Global Biosuperior Sales by Application (2021-2026) & (US$ Million) Table 57. Global Biosuperior Sales Market Share in Value by Application (2021-2026) Table 58. Global Biosuperior Price by Application (2021-2026) & (US$/unit) Table 59. Global Biosuperior Sales by Application (2027-2032) & (k units) Table 60. Global Biosuperior Sales Market Share in Volume by Application (2027-2032) Table 61. Global Biosuperior Sales by Application (2027-2032) & (US$ Million) Table 62. Global Biosuperior Sales Market Share in Value by Application (2027-2032) Table 63. Global Biosuperior Price by Application (2027-2032) & (US$/unit) Table 64. North America Biosuperior Sales by Application (2021-2026) & (k units) Table 65. North America Biosuperior Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Biosuperior Sales by Application (2021-2026) & (k units) Table 67. Europe Biosuperior Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Biosuperior Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Biosuperior Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Biosuperior Sales by Application (2021-2026) & (k units) Table 71. Latin America Biosuperior Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Biosuperior Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Biosuperior Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Company Information Table 75. Teva Business Overview Table 76. Teva Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Teva Biosuperior Product Portfolio Table 78. Teva Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Sanofi Biosuperior Product Portfolio Table 83. Sanofi Recent Development Table 84. Novo Nordisk Company Information Table 85. Novo Nordisk Business Overview Table 86. Novo Nordisk Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Novo Nordisk Biosuperior Product Portfolio Table 88. Novo Nordisk Recent Development Table 89. Merck and Co. Company Information Table 90. Merck and Co. Business Overview Table 91. Merck and Co. Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Merck and Co. Biosuperior Product Portfolio Table 93. Merck and Co. Recent Development Table 94. Eli Lily and Company Company Information Table 95. Eli Lily and Company Business Overview Table 96. Eli Lily and Company Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Eli Lily and Company Biosuperior Product Portfolio Table 98. Eli Lily and Company Recent Development Table 99. Biogen Company Information Table 100. Biogen Business Overview Table 101. Biogen Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Biogen Biosuperior Product Portfolio Table 103. Biogen Recent Development Table 104. SERVIER Company Information Table 105. SERVIER Business Overview Table 106. SERVIER Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. SERVIER Biosuperior Product Portfolio Table 108. SERVIER Recent Development Table 109. Porton Biopharma Company Information Table 110. Porton Biopharma Business Overview Table 111. Porton Biopharma Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Porton Biopharma Biosuperior Product Portfolio Table 113. Porton Biopharma Recent Development Table 114. F.Hoffmann-La Roche AG Company Information Table 115. F.Hoffmann-La Roche AG Business Overview Table 116. F.Hoffmann-La Roche AG Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. F.Hoffmann-La Roche AG Biosuperior Product Portfolio Table 118. F.Hoffmann-La Roche AG Recent Development Table 119. CSL Behring GmbH Company Information Table 120. CSL Behring GmbH Business Overview Table 121. CSL Behring GmbH Biosuperior Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. CSL Behring GmbH Biosuperior Product Portfolio Table 123. CSL Behring GmbH Recent Development Table 124. North America Biosuperior Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. North America Biosuperior Sales by Country (2021-2026) & (k units) Table 126. North America Biosuperior Sales Market Share by Country (2021-2026) Table 127. North America Biosuperior Sales Forecast by Country (2027-2032) & (k units) Table 128. North America Biosuperior Sales Market Share Forecast by Country (2027-2032) Table 129. North America Biosuperior Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Biosuperior Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Biosuperior Market Share by Country (2021-2026) Table 132. North America Biosuperior Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Biosuperior Market Share Forecast by Country (2027-2032) Table 134. Europe Biosuperior Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Europe Biosuperior Sales by Country (2021-2026) & (k units) Table 136. Europe Biosuperior Sales Market Share by Country (2021-2026) Table 137. Europe Biosuperior Sales Forecast by Country (2027-2032) & (k units) Table 138. Europe Biosuperior Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Biosuperior Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Biosuperior Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Biosuperior Market Share by Country (2021-2026) Table 142. Europe Biosuperior Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Biosuperior Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Biosuperior Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Biosuperior Sales by Country (2021-2026) & (k units) Table 146. Asia-Pacific Biosuperior Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Biosuperior Sales Forecast by Country (2027-2032) & (k units) Table 148. Asia-Pacific Biosuperior Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Biosuperior Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Biosuperior Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Biosuperior Market Share by Country (2021-2026) Table 152. Asia-Pacific Biosuperior Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Biosuperior Market Share Forecast by Country (2027-2032) Table 154. Latin America Biosuperior Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Latin America Biosuperior Sales by Country (2021-2026) & (k units) Table 156. Latin America Biosuperior Sales Market Share by Country (2021-2026) Table 157. Latin America Biosuperior Sales Forecast by Country (2027-2032) & (k units) Table 158. Latin America Biosuperior Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Biosuperior Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Biosuperior Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Biosuperior Market Share by Country (2021-2026) Table 162. Latin America Biosuperior Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Biosuperior Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Biosuperior Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Biosuperior Sales by Country (2021-2026) & (k units) Table 166. Middle East and Africa Biosuperior Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Biosuperior Sales Forecast by Country (2027-2032) & (k units) Table 168. Middle East and Africa Biosuperior Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Biosuperior Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Biosuperior Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Biosuperior Market Share by Country (2021-2026) Table 172. Middle East and Africa Biosuperior Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Biosuperior Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Biosuperior Distributors List Table 177. Biosuperior Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Biosuperior Image Figure 2. Global Biosuperior Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biosuperior Market Size (2021-2032) & (US$ Million) Figure 4. Global Biosuperior Sales (2021-2032) & (k units) Figure 5. Insulin Biobetters Image Figure 6. Global Insulin Biobetters Sales YoY Growth (2021-2032) & (k units) Figure 7. Monoclonal Antibodies Biobetters Image Figure 8. Global Monoclonal Antibodies Biobetters Sales YoY Growth (2021-2032) & (k units) Figure 9. Erythropoietin Biobetters Image Figure 10. Global Erythropoietin Biobetters Sales YoY Growth (2021-2032) & (k units) Figure 11. G-CSF Biobetters Image Figure 12. Global G-CSF Biobetters Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Biosuperior Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Biosuperior Market Share by Type 2025 VS 2032 Figure 17. North America Biosuperior Sales Market Share in Volume by Type in 2025 Figure 18. North America Biosuperior Sales Market Share in Value by Type in 2025 Figure 19. Europe Biosuperior Sales Market Share in Volume by Type in 2025 Figure 20. Europe Biosuperior Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Biosuperior Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Biosuperior Sales Market Share in Value by Type in 2025 Figure 23. Latin America Biosuperior Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Biosuperior Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Biosuperior Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Biosuperior Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Biosuperior Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Genetic Disease Image Figure 30. Global Genetic Disease Sales YoY Growth (2021-2032) & (k units) Figure 31. Diabetes Image Figure 32. Global Diabetes Sales YoY Growth (2021-2032) & (k units) Figure 33. Neurological Disorders Image Figure 34. Global Neurological Disorders Sales YoY Growth (2021-2032) & (k units) Figure 35. Cancer Image Figure 36. Global Cancer Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Biosuperior Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Biosuperior Market Share by Application 2025 VS 2032 Figure 41. North America Biosuperior Sales Market Share in Volume by Application in 2025 Figure 42. North America Biosuperior Sales Market Share in Value by Application in 2025 Figure 43. Europe Biosuperior Sales Market Share in Volume by Application in 2025 Figure 44. Europe Biosuperior Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Biosuperior Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Biosuperior Sales Market Share in Value by Application in 2025 Figure 47. Latin America Biosuperior Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Biosuperior Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Biosuperior Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Biosuperior Sales Market Share in Value by Application in 2025 Figure 51. North America Biosuperior Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Biosuperior Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Biosuperior Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Biosuperior Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Biosuperior Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Biosuperior Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Biosuperior Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Biosuperior Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Biosuperior Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Biosuperior Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Biosuperior Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Biosuperior Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Biosuperior Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Biosuperior Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Biosuperior Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Biosuperior Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Biosuperior Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Biosuperior Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Biosuperior Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Biosuperior Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Biosuperior Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Biosuperior Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Biobetters
  • Monoclonal Antibodies Biobetters
  • Erythropoietin Biobetters
  • G-CSF Biobetters
  • Others
Applications
  • Genetic Disease
  • Diabetes
  • Neurological Disorders
  • Cancer
  • Others
Companies covered
  • Teva
  • Sanofi
  • Novo Nordisk
  • Merck and Co.
  • Eli Lily and Company
  • Biogen
  • SERVIER
  • Porton Biopharma
  • F.Hoffmann-La Roche AG
  • CSL Behring GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biosuperior Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biosuperior Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biosuperior Market by Type
  6. 1.3.1 Insulin Biobetters
  7. 1.3.2 Monoclonal Antibodies Biobetters
  8. 1.3.3 Erythropoietin Biobetters
  9. 1.3.4 G-CSF Biobetters
  10. 1.3.5 Others
  11. 1.4 Global Biosuperior Market Size by Type
  12. 1.4.1 Global Biosuperior Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Biosuperior Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Biosuperior Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Biosuperior Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Biosuperior Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Biosuperior Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Biosuperior Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Biosuperior Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biosuperior Industry Trends
  2. 2.2 Biosuperior Industry Drivers
  3. 2.3 Biosuperior Industry Opportunities and Challenges
  4. 2.4 Biosuperior Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biosuperior Revenue (2021-2026)
  2. 3.2 Global Top Players by Biosuperior Sales (2021-2026)
  3. 3.3 Global Top Players by Biosuperior Price (2021-2026)
  4. 3.4 Global Biosuperior Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biosuperior Major Company Production Sites & Headquarters
  6. 3.6 Global Biosuperior Company, Product Type & Application
  7. 3.7 Global Biosuperior Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biosuperior Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biosuperior Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biosuperior Tier 1, Tier 2, and Tier 3
4 Biosuperior Regional Status and Outlook
  1. 4.1 Global Biosuperior Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biosuperior Historic Market Size by Region
  3. 4.2.1 Global Biosuperior Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biosuperior Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biosuperior Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biosuperior Forecasted Market Size by Region
  7. 4.3.1 Global Biosuperior Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biosuperior Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biosuperior Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biosuperior by Application
  1. 5.1 Biosuperior Market by Application
  2. 5.1.1 Genetic Disease
  3. 5.1.2 Diabetes
  4. 5.1.3 Neurological Disorders
  5. 5.1.4 Cancer
  6. 5.1.5 Others
  7. 5.2 Global Biosuperior Market Size by Application
  8. 5.2.1 Global Biosuperior Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Biosuperior Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Biosuperior Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Biosuperior Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Biosuperior Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Biosuperior Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Biosuperior Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Biosuperior Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Biosuperior Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Biosuperior Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novo Nordisk
  14. 6.3.1 Novo Nordisk Company Information
  15. 6.3.2 Novo Nordisk Business Overview
  16. 6.3.3 Novo Nordisk Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novo Nordisk Biosuperior Product Portfolio
  18. 6.3.5 Novo Nordisk Recent Developments
  19. 6.4 Merck and Co.
  20. 6.4.1 Merck and Co. Company Information
  21. 6.4.2 Merck and Co. Business Overview
  22. 6.4.3 Merck and Co. Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck and Co. Biosuperior Product Portfolio
  24. 6.4.5 Merck and Co. Recent Developments
  25. 6.5 Eli Lily and Company
  26. 6.5.1 Eli Lily and Company Company Information
  27. 6.5.2 Eli Lily and Company Business Overview
  28. 6.5.3 Eli Lily and Company Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lily and Company Biosuperior Product Portfolio
  30. 6.5.5 Eli Lily and Company Recent Developments
  31. 6.6 Biogen
  32. 6.6.1 Biogen Company Information
  33. 6.6.2 Biogen Business Overview
  34. 6.6.3 Biogen Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Biogen Biosuperior Product Portfolio
  36. 6.6.5 Biogen Recent Developments
  37. 6.7 SERVIER
  38. 6.7.1 SERVIER Company Information
  39. 6.7.2 SERVIER Business Overview
  40. 6.7.3 SERVIER Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SERVIER Biosuperior Product Portfolio
  42. 6.7.5 SERVIER Recent Developments
  43. 6.8 Porton Biopharma
  44. 6.8.1 Porton Biopharma Company Information
  45. 6.8.2 Porton Biopharma Business Overview
  46. 6.8.3 Porton Biopharma Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Porton Biopharma Biosuperior Product Portfolio
  48. 6.8.5 Porton Biopharma Recent Developments
  49. 6.9 F.Hoffmann-La Roche AG
  50. 6.9.1 F.Hoffmann-La Roche AG Company Information
  51. 6.9.2 F.Hoffmann-La Roche AG Business Overview
  52. 6.9.3 F.Hoffmann-La Roche AG Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 F.Hoffmann-La Roche AG Biosuperior Product Portfolio
  54. 6.9.5 F.Hoffmann-La Roche AG Recent Developments
  55. 6.10 CSL Behring GmbH
  56. 6.10.1 CSL Behring GmbH Company Information
  57. 6.10.2 CSL Behring GmbH Business Overview
  58. 6.10.3 CSL Behring GmbH Biosuperior Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CSL Behring GmbH Biosuperior Product Portfolio
  60. 6.10.5 CSL Behring GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Biosuperior Sales by Country
  2. 7.1.1 North America Biosuperior Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biosuperior Sales by Country (2021-2026)
  4. 7.1.3 North America Biosuperior Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biosuperior Market Size by Country
  6. 7.2.1 North America Biosuperior Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biosuperior Market Size by Country (2021-2026)
  8. 7.2.3 North America Biosuperior Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biosuperior Sales by Country
  2. 8.1.1 Europe Biosuperior Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biosuperior Sales by Country (2021-2026)
  4. 8.1.3 Europe Biosuperior Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biosuperior Market Size by Country
  6. 8.2.1 Europe Biosuperior Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biosuperior Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biosuperior Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biosuperior Sales by Country
  2. 9.1.1 Asia-Pacific Biosuperior Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biosuperior Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biosuperior Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biosuperior Market Size by Country
  6. 9.2.1 Asia-Pacific Biosuperior Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biosuperior Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biosuperior Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biosuperior Sales by Country
  2. 10.1.1 South America Biosuperior Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biosuperior Sales by Country (2021-2026)
  4. 10.1.3 South America Biosuperior Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biosuperior Market Size by Country
  6. 10.2.1 South America Biosuperior Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biosuperior Market Size by Country (2021-2026)
  8. 10.2.3 South America Biosuperior Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biosuperior Sales by Country
  2. 11.1.1 Middle East and Africa Biosuperior Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biosuperior Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biosuperior Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biosuperior Market Size by Country
  6. 11.2.1 Middle East and Africa Biosuperior Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biosuperior Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biosuperior Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biosuperior Value Chain Analysis
  2. 12.1.1 Biosuperior Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biosuperior Production Mode & Process
  7. 12.2 Biosuperior Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biosuperior Distributors
  10. 12.2.3 Biosuperior Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst